<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489278</url>
  </required_header>
  <id_info>
    <org_study_id>20170785</org_study_id>
    <secondary_id>U54NS092091</secondary_id>
    <nct_id>NCT03489278</nct_id>
  </id_info>
  <brief_title>Clinical Procedures to Support Research</brief_title>
  <acronym>CAPTURE</acronym>
  <official_title>Clinical Procedures to Support Research (CAPTURE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muscular Dystrophy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Advancing Translational Science (NCATS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize
      information collected in the medical record to learn more about a disease called amyotrophic
      lateral sclerosis (ALS) and related disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consent patients with ALS or related disorders that are receiving care at a
      clinical center in the CReATe consortium that uses Epic as its electronic health record (EHR)
      system. The study aims to systematically gather a clinical dataset through the EHR using a
      standardized approach to characterize the natural history of ALS and related diseases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2018</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Using the ALS Toolkit for collecting and using electronic health record data for research purposes</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>ALS-Frontotemporal Dementia</condition>
  <condition>Primary Lateral Sclerosis</condition>
  <condition>Progressive Muscular Atrophy</condition>
  <arm_group>
    <arm_group_label>Affected</arm_group_label>
    <description>Affected with ALS or a related disorder.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Optional: Provide blood for a DNA sample during a clinic visit. Participants can choose to
      allow collection of information from their medical record, but choose not to give a blood
      sample for testing.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Affected patients receiving care at a clinical center that uses Epic as EHR.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of ALS or a related disorder (e.g. primary lateral sclerosis, progressive
             muscular atrophy).

          -  Receiving care at a clinical center that uses Epic as its EHR.

          -  Able and willing to provide informed consent (or informed consent obtainable from a
             designated proxy).

        Exclusion Criteria:

          -  Inability to understand English and/or Spanish
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Benatar, MBChB, MS, DPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Benatar, MBChB, MS, DPhil</last_name>
    <phone>1-844-837-1031</phone>
    <email>projectcreate@miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sumaira Hussain</last_name>
    <phone>1-844-837-1031</phone>
    <email>projectcreate@miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon Carty</last_name>
      <phone>415-600-1368</phone>
      <email>cartys@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>Jonathan Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Laure Grignon</last_name>
      <phone>305-243-8928</phone>
      <email>projectcreate@miami.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Benatar, MBChB, MS, DPhil</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Michael Benatar</investigator_full_name>
    <investigator_title>Chief, Neuromuscular Division</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

